Investor News / RNS

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has completed a revised placing, conditional on admission to trading on AIM, of, in aggregate, £490,000.00 (gross) from the issue of 122,500,000 new ordinary shares (the “Placing Shares”) at an issue price of £0.004 per Placing...

Read More

The directors of Physiomics plc (AIM: PYC) announce that at 2114h on 13 March 2026 they received a request submitted pursuant to section 303 of the Companies Act 2006 (the "Act") requiring the Board to convene a general meeting of the Company's shareholders (the "GM Request"). The GM Request was accompanied by a shareholder statement submitted pursuant to section 314 of the Act.   The GM Request...

Read More

Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 10 March 2026.     Physiomics plc (AIM: PYC), is pleased to announce, further to the announcements made on 10 March 2026, the completion of the WRAP Retail Offer, at the same issue price as the previously announced Placing (together the “Fundraise”). The WRAP...

Read More

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has completed a placing, conditional on certain resolutions being passed at a general meeting of the Company (the “General Meeting”) and admission to trading on AIM, of, in aggregate, £449,999.88 (gross) from the issue of 149,999,960...

Read More